News

The integration aims to build a consistent system of manufacturing everything from intermediates to API while utilizing scientific research capabilities to enhance the manufacturing technology infrastructure and make

Invokana is the oral, once-daily medication available in the US demonstrating improved glycemic control and reduced body weight and systolic blood pressure in clinical trials. Janssen Pharmaceuticals medical

The company submitted a new drug application to FDA based on Phase 3 data in treatment-naïve and treatment-experienced patients with compensated liver disease. Application is filed for administration

The launch follows the FDA approval of the company’s ANDA for Zenatane 10mg, 20mg and 40mg. Zenatane (Isotretinoin Capsules USP) is a generic version, therapeutically equivalent to Accutane

Quartette, designed as next generation of extended regimen oral contraceptives, will reduce breakthrough bleeding (BTB) between scheduled periods. Because of the 91-day oral regimen, an increase in estrogen

The research collaboration will use KineMed’s dynamic proteomics technology platform to map the impact of potential drug candidates on specific metabolic pathways. KineMed R&D executive vice-president Dr. Scott

Using proprietary DNA sequences, the non-invasive molecular diagnostic test will identify the presence or absence of fifteen known high-risk HPV strains. The urine-based HPV-HR DNA test can facilitate

Innovation Network Corporation of Japan, a fund managed by Mitsubishi UFJ Capital, and Daiichi Sankyo have jointly invested in the Orphan Disease Treatment Institute. With the opening of

The WIN Consortium is a network of academic, industry, and patient advocacy organizations that works on bringing personalized cancer care to patients across the world. WIN Consortium delegate